BERTOLINI, Federica
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.285
EU - Europa 3.199
AS - Asia 695
SA - Sud America 5
AF - Africa 4
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 7.190
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.274
IT - Italia 1.934
GB - Regno Unito 410
SE - Svezia 219
SG - Singapore 210
CN - Cina 206
DE - Germania 190
HK - Hong Kong 116
UA - Ucraina 101
FI - Finlandia 75
FR - Francia 62
RU - Federazione Russa 48
IN - India 41
TR - Turchia 40
BG - Bulgaria 35
ID - Indonesia 35
IE - Irlanda 25
CH - Svizzera 17
BE - Belgio 16
NL - Olanda 16
LT - Lituania 11
VN - Vietnam 11
MY - Malesia 10
RO - Romania 10
CA - Canada 9
CZ - Repubblica Ceca 8
AT - Austria 5
ES - Italia 5
IR - Iran 5
AE - Emirati Arabi Uniti 3
IL - Israele 3
JP - Giappone 3
AL - Albania 2
BD - Bangladesh 2
CL - Cile 2
DK - Danimarca 2
GQ - Guinea Equatoriale 2
GR - Grecia 2
KR - Corea 2
MG - Madagascar 2
PE - Perù 2
PK - Pakistan 2
PL - Polonia 2
TW - Taiwan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
BR - Brasile 1
BZ - Belize 1
HR - Croazia 1
HU - Ungheria 1
KZ - Kazakistan 1
MT - Malta 1
MX - Messico 1
NZ - Nuova Zelanda 1
PT - Portogallo 1
SA - Arabia Saudita 1
TH - Thailandia 1
Totale 7.190
Salva come PNG Salva come JPEG
Città #
Santa Clara 484
Fairfield 374
Chandler 353
Southend 299
Ashburn 237
Woodbridge 198
Singapore 164
Houston 152
Nyköping 151
Jacksonville 140
Milan 137
Wilmington 130
Seattle 128
Rome 124
Cambridge 118
Hong Kong 114
Dearborn 111
Ann Arbor 106
Bologna 73
Helsinki 57
Modena 54
New York 54
San Diego 50
Beijing 44
Princeton 38
Jakarta 35
Sofia 33
Naples 32
Shanghai 28
Turin 28
Izmir 26
Eugene 25
Dublin 24
Bari 22
Munich 21
Padova 19
Bremen 16
Brescia 16
Brussels 16
Des Moines 16
London 16
Verona 16
Catania 15
Genoa 15
Moscow 15
Castelnuovo Rangone 14
Palermo 13
Torino 13
Parma 12
San Mateo 12
Florence 11
Fremont 11
Los Angeles 11
Redwood City 11
Dong Ket 10
Lucca 10
Falls Church 9
Treviso 9
Hefei 8
Norwalk 8
Vignola 8
Afragola 7
Boardman 7
Forlì 7
Gurugram 7
Hounslow 7
Napoli 7
Ottawa 7
Perugia 7
Pisa 7
Trieste 7
Brno 6
Chicago 6
Livorno 6
Lugano 6
Mumbai 6
Reggio Emilia 6
Andover 5
Kunming 5
Lecce 5
Nanjing 5
New Delhi 5
Oderzo 5
Paris 5
San Giovanni Rotondo 5
Storo 5
Venice 5
Washington 5
Bergamo 4
Chieti 4
Civitanova Marche 4
Cornigliano 4
Deiva Marina 4
Ferrara 4
Guangzhou 4
Lissone 4
Monza 4
Ragusa 4
Seriate 4
Adelfia 3
Totale 4.702
Salva come PNG Salva come JPEG
Nome #
Un caso inusuale di interstiziopatia polmonare cistica 1.801
SVILUPPO DI IPOGAMMAGLOBULINEMIA IN PAZIENTI TRATTATI CON IMATINIB PER LEUCEMIA MIELOIDE CRONICA O TUMORI STROMALI GASTROINTESTINALI 304
A Dose-finding and Biomarker Evaluation Phase Ib Study of Everolimus in Association With 5-Fluorouracil and Pelvic Radiotherapy as Neoadjuvant Treatment of Locally Advanced Rectal Cancer (E-LARC Study) 230
FOLFOX6 and bevacizumab in non-optimally resectable liver metastases from colorectal cancer 215
Correction to: Which elderly newly diagnosed glioblastoma patients can benefit from radiotherapy and temozolomide? A PERNO prospective study (Journal of Neuro-Oncology, (2016), 128, 1, (157-162), 10.1007/s11060-016-2093-1) 206
Brain metastases: an overview 204
Overall survival in patients with lung adenocarcinoma harboring "niche" mutations: an observational study 201
Prognostic and Predictive Value of Baseline and Posttreatment Molecular Marker Expression in Locally Advanced Rectal Cancer Treated With Neoadjuvant Chemoradiotherapy 194
Body composition and inflammation impact in non-small cell lung cancer patients treated by first-line immunotherapy 192
Sorafenib in patients with advanced biliary tract carcinoma: a phase II trial 187
Role of evaluating tumor‑infiltrating lymphocytes, programmed death‑1 ligand 1 and mismatch repair proteins expression in malignant mesothelioma 186
Incidence and clinicopathologic features of gastrointestinal stromal tumors. A population-based study. 182
Prognostic value of Dworak grade of regression (GR) in patients with rectal carcinoma treated with preoperative radiochemotherapy 182
Cerebrospinal fluid cytology in a case of primary diffuse leptomeningeal and pineal melanocytic lesion, with histological confirmation 181
Incidence and clinical impact of sterilized disease and minimal residual disease after preoperative radiochemotherapy for rectal cancer 176
ALDH Expression in Angiosarcoma of the Lung: A Potential Marker of Aggressiveness? 175
Gastrointestinal stromal tumor and other primary metachronous and synchronous neoplasms as a suspicious criterion for syndromic setting 172
Prognostic value of "Dworak" tumor regression grade (TRG) after pre-operative chemo-radiotherapy in rectal cancer (RC) 159
Expression of ALDH and SOX-2 in Pulmonary Sclerosing Pnemocytoma (PSP) of the Lung: Is There a Meaning Behind? 156
Treating cancer with immunotherapy in HIV-positive patients: A challenging reality 141
IMPROVED SURVIVAL AFTER RADIOTHERAPY FOR BRAIN METASTASES IN PATIENTS WITH HER2 POSITIVE BREAST TUMORS 134
Bone metastases- Pharmacological treatment 131
Retospective analysis of resectability, prognostic factors and outcome of cholangiocellular carcinoma (CCC) 127
Pulmonary strongyloidiasis mimicking cancer symptoms: A case of hyperinfection in a patient with metastatic lung cancer 125
GLIOMATOSIS CEREBRI: A SINGLE INSTITUTION REPORT 121
Retrospective analysis of resectability, prognostic factors and outcome of cholangiocellular carcinoma (CCC) 119
Corrigendum to Expression of 19 microRNAs in glioblastoma and comparison with other brain neoplasia of grades I-III [Mol. Oncol. 8 (2) (2014) 417-30] 116
Prognostic value of total tumor regression after pre-operative chemo-radiotherapy in rectal cancer (RC) 112
I tumori stromali gastrointestinali: realtà clinica in continua evoluzione. Caso clinico 110
Laparoscopic approach of gastric gastrointestinal stromal tumors (GISTs): Is it still a courageous choice? Report of two cases 107
Corrigendum: A Real-World, Multicenter, Observational Retrospective Study of Durvalumab After Concomitant or Sequential Chemoradiation for Unresectable Stage III Non-Small Cell Lung Cancer (Front. Oncol., (2021), 11, (744956), 10.3389/fonc.2021.744956) 107
Deepening the knowledge of ros1 rearrangements in non-small cell lung cancer: Diagnosis, treatment, resistance and concomitant alterations 87
A Real-World, Multicenter, Observational Retrospective Study of Durvalumab After Concomitant or Sequential Chemoradiation for Unresectable Stage III Non-Small Cell Lung Cancer 79
Dissecting Immunotherapy Strategies for Small Cell Lung Cancer: Antibodies, Ionizing Radiation and CAR-T 73
The NIPRO Study: An Observational, Retrospective, Multicenter Study on the Safety of the Radiotherapy and Immunotherapy Combination for Advanced-Stage NSCLC 73
Oligorecurrent Non-Small-Cell Lung Cancer Treated by Chemo-Radiation Followed by Immunotherapy and Intracranial Radiosurgery: A Case Report and Mini Review of Literature 56
Adding Concomitant Chemotherapy to Postoperative Radiotherapy in Oral Cavity Carcinoma with Minor Risk Factors: Systematic Review of the Literature and Meta-Analysis 52
Osteoblastic Flare During Chemo-Immunotherapy in Small Cell Lung Cancer: Do Not Be Misleaded! 42
null 26
mTOR Pathway Expression as Potential Predictive Biomarker in Patients with Advanced Neuroendocrine Tumors Treated with Everolimus 26
Complete and durable regression of leptomeningeal involvement during lorlatinib treatment in a patient with lung cancer 1
Totale 7.268
Salva come PNG Salva come JPEG
Categoria #
all - tutte 26.577
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.577
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020596 0 0 0 0 0 136 143 86 90 40 64 37
2020/2021963 82 87 106 59 104 74 62 82 53 87 113 54
2021/2022867 43 85 61 67 21 59 52 26 99 63 184 107
2022/20231.270 104 121 132 110 107 160 54 141 156 39 73 73
2023/20241.094 57 49 89 108 140 94 130 120 53 71 91 92
2024/20251.154 113 53 94 165 409 320 0 0 0 0 0 0
Totale 7.268